CVS Health Files 8-K Report
Ticker: CVS · Form: 8-K · Filed: Nov 20, 2025 · CIK: 64803
| Field | Detail |
|---|---|
| Company | Cvs Health CORP (CVS) |
| Form Type | 8-K |
| Filed Date | Nov 20, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, sec-filing
Related Tickers: CVS
TL;DR
CVS Health filed an 8-K on 11/20/25. No major news, just standard disclosures.
AI Summary
CVS Health Corporation filed an 8-K report on November 20, 2025, to disclose information regarding other events and financial statements. The filing does not contain specific details about new transactions, material events, or financial figures within the provided text.
Why It Matters
This 8-K filing indicates that CVS Health is providing updates or disclosures to the SEC, which could be relevant for investors monitoring the company's regulatory compliance and corporate actions.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report without specific material events or financial disclosures that would immediately impact risk.
Key Players & Entities
- CVS HEALTH Corp (company) — Registrant
- November 20, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-01011 (identifier) — Commission File Number
- 05-0494040 (identifier) — I.R.S. Employer Identification No.
- One CVS Drive Woonsocket, Rhode Island 02895 (address) — Principal Executive Offices
- (401) 765-1500 (phone_number) — Registrant's Telephone Number
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is November 20, 2025.
What is the Commission File Number for CVS HEALTH Corporation?
The Commission File Number for CVS HEALTH Corporation is 001-01011.
In which state is CVS HEALTH Corporation incorporated?
CVS HEALTH Corporation is incorporated in Delaware.
What is the address of the Principal Executive Offices for CVS HEALTH Corporation?
The address of the Principal Executive Offices is One CVS Drive Woonsocket, Rhode Island 02895.
What are the main items disclosed in this 8-K filing?
This 8-K filing pertains to 'Other Events' and 'Financial Statements and Exhibits'.
Filing Stats: 532 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-11-20 16:18:11
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchan
Filing Documents
- d172430d8k.htm (8-K) — 25KB
- d172430dex991.htm (EX-99.1) — 4KB
- g172430g1118230839704.jpg (GRAPHIC) — 2KB
- 0001193125-25-289805.txt ( ) — 145KB
- cvs-20251120.xsd (EX-101.SCH) — 3KB
- cvs-20251120_lab.xml (EX-101.LAB) — 17KB
- cvs-20251120_pre.xml (EX-101.PRE) — 11KB
- d172430d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated November 20, 2025. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: November 20, 2025 CVS HEALTH CORPORATION By: /s/ Kristina V. Fink Name: Kristina V. Fink Title: Senior Vice President, Chief Governance Officer and Corporate Secretary